Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The record history now includes core results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with More Information and Limitations and Caveats; the previous entry 'Results Submitted' appears to be removed.
    Difference
    1%
    Check dated 2025-12-09T18:59:38.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added to the Record History, replacing the previous v3.2.0. No substantive changes to the study information are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the general government funding/operating status notice from the page. The notice previously informed users about potential downtime and where to check for updates (opm.gov).
    Difference
    0.7%
    Check dated 2025-11-18T06:53:21.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    New version entry dated 2025-02-12 shows updated Recruitment Status and ongoing Study Status details in the record history. The change reflects current trial activity and availability information as recorded on ClinicalTrials.gov.
    Difference
    0.2%
    Check dated 2025-11-03T20:43:54.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The record history shows two new Results Submission Events and one removed, reflecting updates to how results submissions are tracked. This is an administrative log update and does not modify the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-27T15:11:04.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.